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2The PROSPECT (Providing Regional Observa-
tions to Study Predictors of Events in the Coronary
Tree) study was a prospective, observational study
in 697 patients undergoing percutaneous coronary
intervention for acute coronary syndromes (1). The
study was designed to assess the natural history of
coronary atherosclerosis using multimodality intra-
vascular imaging to identify those clinical and
lesion-related factors that would predict future clin-
ical events. After intervention of the culprit lesion,
the 3 epicardial arteries underwent screening of the
proximal 6 to 8 cm for “vulnerable plaques” using
intravascular ultrasound (IVUS), including compo-
sitional (IVUS–virtual histology [VH]) and me-
chanical (palpography) plaque characterization. As-
sessed by angiography, most new nonculprit-related
See pages S1, S10, and S19
events originated from mild lesions. Larger plaque
burden (70%) and smaller minimal luminal area
(4.0 mm2) by IVUS and the presence of a
VH-defined thin-cap fibroatheroma (TCFA) were
independently associated with an increased risk for
subsequent events. Those few lesions that possessed
all 3 characteristics had an 18.2% rate of major
cardiovascular events during the 3.4-year follow-up
period. However, the predictive power of VH-
defined TCFA alone was low, mainly because of
poor specificity. Of 595 TCFAs identified by VH,
only 26 led to coronary events during follow-up.
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
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disclose.The data generated offer an important evaluation
f the incidence and causes of recurrent events in
he setting of current preventive strategies for high-
isk patients. Overall, 20.4% of patients had major
ardiovascular events, of which 11.6% were related
o nonculprit lesions; however, only 1% were myo-
ardial infarctions, while the remaining 10.8% were
nstable or progressive angina. In addition, 1.6% of
atients had vascular injuries from the imaging
rocedures. Hence, 1 interpretation of the data is
hat given the current success in reducing death and
yocardial infarction, the increased risk of per-
orming 3-vessel invasive imaging to locate and
hen prophylactically treat presumed high-risk le-
ions is not warranted.
he Vulnerable Plaque Concept
oth of us participated in the 1st Vulnerable Plaque
eeting in 2003 on the Greek island of Santorini,
hich produced a consensus document in which it
as proposed to use synonymously the terms “high-
isk,” “vulnerable,” and “thrombosis-prone” plaques
or plaques at increased risk for subsequent throm-
osis and rapid stenosis progression (2). Plaque
upture is by far the most common cause of coro-
ary thrombosis, underlying about 75% of all cases
3). By inference, the most common type of vulner-
ble plaque is the rupture-prone plaque, also called
TCFA. It is assumed to look like a ruptured
laque, only without surface disruption and throm-
osis. The size of the lipid-rich necrotic core, the
hickness of the fibrous cap covering the core, and
he degree of cap inflammation appear to be the
ajor determinants of subsequent plaque rupture.
he remaining coronary thrombi are caused by less
ell-defined mechanisms, of which “plaque ero-
ion” is the most common type, present in about
5% of patients, generally women (2,3). Erosion-
rone vulnerable plaques are heterogeneous and de-
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S39fined only by their fate (thrombosis), as no distinct
morphological features other than the absence of
endothelial coverage have been identified. The key
questions are thus whether vulnerable plaques, in
particular TCFA, can be prospectively identified and,
if so, prophylactically treated to reduce the lesion-
related risk of future coronary events. PROSPECT
was designed to answer the first question.
Prospective Identiﬁcation
of Vulnerable Plaques
The preceding 3 reports (4–6) present information
on the performance of the PROSPECT study and
the analysis of its results. Maehara et al. (4) provide
insights about definitions and methodology for
IVUS (grayscale and VH) and coronary angiogra-
phy used to identify lesion-related predictors of
subsequent coronary events. Performance and anal-
ysis of the data were challenging. New approaches,
algorithms, and software were developed to permit
coregistration of angiographic and IVUS images,
and detailed analysis was performed at a level not
previously attempted. The required analyses required
at least 1 day/patient for angiographic analysis, while
grayscale and VH-IVUS results required on average
2.3 days/patient. The size for the entire image set was
2.1 gigabytes/patient. As a result, the study produced
an enormous dataset, and the investigators must be
congratulated for this outstanding achievement.
On the basis of pre-specified characteristics of
necrotic core, dense calcium, and cap thickness, 10
fibroatheroma subtypes were defined and ordered
hierarchically based on anticipated risk for subse-
quent plaque-related events. The investigators are
forthright in describing the potential pitfalls of the
PROSPECT data acquisition and analysis and im-
portant limitations of IVUS-VH for compositional
plaque assessment, including insufficient spatial reso-
lution to truly detect a thin fibrous cap or missing
endothelium (important for assessment of plaque ero-
sion), artificial VH-defined necrotic core in the
shadow behind dense calcium, artificial VH-defined
calcium near the lumen, and erroneous tissue coding
of thrombus. Thus, the investigators acknowledge that
error in the VH assessment of the presence of TCFAs
may have been introduced. Furthermore, the distinc-
tion between fibroatheromas considered unstable (vul-
nerable) and those considered stable was based on
arbitrary cut points for VH-defined necrotic core size
(10% confluent) and extent of core-to-lumen prox-
mity (30°). No compelling arguments are provided
or the choice of either of these cut points, which differ
ignificantly from the criteria used to define a TCFA lt necropsy, in which the sizes of necrotic cores of
table plaques, TCFAs, and ruptured plaques aver-
ged 12%, 23%, and 34%, respectively (7). Even given
hese limitations, the report by Maehara et al. will be
f great use, as well as act as a cautionary tale, for those
nvestigators who wish to embark on such a study.
Brugaletta et al. (5) report a subanalysis from the
ROSPECT study in which 114 patients under-
ent simultaneous IVUS-VH–based plaque evalu-
tion and palpography. In this subgroup, there were
6 clinical events and 488 VH-defined fibroathe-
omas identified, of which 111 were VH TCFAs.
ompared with the overall PROSPECT popula-
ion, the expected number of VH TCFAs (111 of
14  1 per patient) is similar but about twice the
expected number of thick-cap fibroatheromas (377
of 114  3.3 per patient vs. 1,018 of 623  1.6 per
patient in PROSPECT [1]). The reason for this
discrepancy is not commented on, but a possible
explanation could be that necrotic core–rich plaques
containing 10% confluent necrotic core were de-
ned as fibroatheromas in this subanalysis but not
n the entire PROSPECT study. The investigators
lso do not explain why one of the most common
esion types, pathological intimal thickening, was
xcluded from the analysis. Indeed, Figure 2 of
rugaletta et al. (5) may show that necrotic core–
ontaining pathological intimal thickenings were
eclassified as fibroatheroma for the purpose of this
ubstudy. Nonetheless, palpography was unable to dis-
inguish between different subtypes of VH-defined fibro-
theromas and did not provide prognostic information of
linical value in this population.
These results are disappointing. Palpography had
reviously been shown to identify vulnerable plaques
n human necropsy samples (8) and to correlate with
linical presentation while reflecting compositional
hange resulting from medical therapy (9). The cur-
ent results call into question any potential role of
alpography in the detection of high-risk lesions and
he discrepancy with previous studies.
In the second PROSPECT substudy, Wykrzykowska
t al. (6) examined the longitudinal distribution of
therosclerotic plaque burden, IVUS-VH necrotic
ore content, and TCFA plaque phenotype in
onculprit lesions. This descriptive analysis of pa-
ients confirms previous data obtained at necropsy,
r with angiography, IVUS, or multislice computed
omographic angiography, namely, that high-risk le-
ions tend to be located more proximally within the
eft coronary artery. The left main coronary artery
ppears to be the exception, as the plaque burden is
ess and the proportion of the lesion taken up by
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S40VH-defined necrotic core is relatively smaller than in
the proximal segments of the other epicardial arteries.
This finding may reflect selection bias, as patients with
smaller left main coronary artery diameters by angiog-
raphy may not have been enrolled in the study. The
right coronary artery also demonstrates less of a
gradient from the proximal to distal vessel.
In this substudy, the percent necrotic core volume
determined by VH was similar in the proximal and
mid segments and only slightly greater than in the
distal segments. This finding is in variance with a
previous study in which the predominant site of
plaque rupture was noted to be in the proximal
segment of the left anterior descending coronary
artery, the entire left circumflex artery, and the prox-
imal and distal segments of the right coronary artery
(10). It would seem logical that the site of the highest
necrotic core volume would be the site of the greatest
risk for plaque rupture leading to clinical ischemic
events, unless plaque morphology and composition are
more dynamic than previous thought.
What Have We Learned Since the First
Vulnerable Plaque Meeting in 2003?
Studies using clinical events as outcomes and those
evaluating diagnostic approaches to determine the
presence of high-risk lesions have shown varying
results. In the COURAGE (Clinical Outcomes
Utilizing Revascularization and Aggressive Drug
Evaluation) trial, stable patients with coronary artery
disease treated aggressively with pharmacologic ther-
apies and lifestyle modification had an 18.5% risk for
death or nonfatal myocardial infarction over a median
4.6-year follow-up (11), while the 3.4-year event rate
of nonculprit lesions in PROSPECT was 11.6%, and
these events were generally progressive angina (1).
herefore, the question arises whether we are evalu-
ting the wrong patient group, and if so, how to better
ocus our attention on truly high-risk patients.
This is important for several reasons. First, given
he difficulty in assessing and properly analyzing
esions evaluated by angiography, IVUS, and
VUS-VH, as shown by Maehara et al. (4), it
ehooves us to ensure that the evaluated patients are
t high risk for death and myocardial infarction. If
e are generally identifying those lesions that will
ubsequently cause angina, we can simply wait for
he event to happen and then perform the necessary
ntervention, thereby reducing the evaluated num-
er of patients and the effort necessary to identifynvasive imaging of the 3 coronary arteries is asso-
iated with a small but present risk for vascular
amage, which may represent a bar too high to
vercome when determining the risk/benefit ratio
f prophylactic treatment for such lesions. Finally,
he cost and organization necessary to make such
nvasive evaluations on a large number of patients
ill make private and/or governmental payers leery.
The development and regression of high-risk
esions may be more dynamic than hitherto
hought. Kubo et al. (12) demonstrated that most
H TCFAs healed during a 1-year follow-up
eriod, while new VH TCFAs developed. Hence, a
-time assessment of the coronary tree may be
nadequate, and serial evaluations are necessary to
etermine the future risk for plaque instability. This
ay be the reason that of the 51 nonculprit lesion–
elated recurrent events observed in PROSPECT,
nly 26 occurred at sites of VH-defined TCFAs.
nother explanation could be insufficient diagnos-
ic performance of IVUS-VH in detecting TCFAs
13). Thus, perhaps after the identification of a
CFA, intensive pharmacologic treatment should be
nitiated, along with serial imaging (preferably nonin-
asive), and only if the TCFA persists should a
rophylactic intervention be performed. Indeed, an
valuation of TCFA behavior after intensive pharma-
ologic treatment would be helpful in this regard.
Finally, the data suggest that determining the pres-
nce of a VH-defined TCFA may not be enough.
nsofar as about 25% of lesions causing coronary
hrombosis are not TCFAs (3), simply focusing on
CFAs will result in a false sense of security if
maging shows no TCFAs and cannot identify lesions
rone to plaque erosion. IVUS-VH cannot detect
hose lesions, or at least the data have not been shown,
nd so it may fall to other imaging protocols to
etermine this important subset of lesions.
PROSPECT was an important, some say land-
ark, study which has led to valuable insights into
he natural history of atherosclerosis. The present
upplement is evidence of the wealth of data that
ave been gleaned from this study. It is our hope
hat studies will be performed to evaluate other
ovel imaging protocols, both invasive and nonin-
asive, to further define the natural history of
igh-risk lesions and the effect of treatment.
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